Angio News and Research

RSS
Study refocuses on how neuroblastoma tumors evolve in response to medicine and other factors

Study refocuses on how neuroblastoma tumors evolve in response to medicine and other factors

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Regenerative medicine: an interview with Christophe Dardel, President of DSM Biomedical

Researchers discover two gene variants that raise risk of pediatric cancer neuroblastoma

Researchers discover two gene variants that raise risk of pediatric cancer neuroblastoma

Kensey Nash to resolve Angio-Seal license disputes with St. Jude Medical

Kensey Nash to resolve Angio-Seal license disputes with St. Jude Medical

IMRIS unveils VISIUS Surgical Theatre

IMRIS unveils VISIUS Surgical Theatre

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Kensey Nash fourth quarter total revenues decrease 14% to $18.7 million

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Positive results for unprotected left main coronary artery PCI with drug-eluting stents

Kensey Nash revenues decrease 7% to $18.6 million for third quarter fiscal 2011

Kensey Nash revenues decrease 7% to $18.6 million for third quarter fiscal 2011

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Positive outcomes from Medtronic's Resolute drug-eluting stent against coronary artery disease

Study finds reduction in pain favoring Mynx Vascular Closure Device to Angio-Seal Evolution Device

Study finds reduction in pain favoring Mynx Vascular Closure Device to Angio-Seal Evolution Device

Story of the heart: Literally as well as metaphorically

Story of the heart: Literally as well as metaphorically

Kensey Nash second quarter revenue decreases to $17.4 million

Kensey Nash second quarter revenue decreases to $17.4 million

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Avantra Biosciences selects TGen Drug Development for new biomarker quantitation platform

Avantra begins shipment of new Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay

Avantra begins shipment of new Q400 Biomarker Workstation and Angio Qx BioChip Immunoassay

LMO1 gene variation can increase neuroblastoma risk

LMO1 gene variation can increase neuroblastoma risk

Kensey Nash 2011 first quarter decreases 14% to $17.0 million

Kensey Nash 2011 first quarter decreases 14% to $17.0 million

St. Jude Medical to highlight OCT product platform at TCT meeting

St. Jude Medical to highlight OCT product platform at TCT meeting

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

St. Jude Medical announces positive subset data results for Angio-Seal Evolution Vascular Closure Device Registry

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

Vascular Solutions to distribute Shepherd Scientific's Angio Assist and Teirstein Edge products in US

New Center for Image-Guided Intervention opened at MSKCC

New Center for Image-Guided Intervention opened at MSKCC